Total Payments
$7,137
2024 Payments
$645.03
Companies
40
Transactions
329
Medicare Patients
875
Medicare Billing
$173,468
Payment Breakdown by Category
Food & Beverage$7,074 (99.1%)
Consulting$40.00 (0.6%)
Education$23.49 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,074 | 324 | 99.1% |
| Consulting Fee | $40.00 | 1 | 0.6% |
| Education | $23.49 | 4 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $972.46 | 45 | $0 (2024) |
| BioDelivery Sciences International, Inc. | $617.64 | 27 | $0 (2021) |
| UCB, Inc. | $601.71 | 25 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $504.05 | 17 | $0 (2024) |
| PFIZER INC. | $458.16 | 24 | $0 (2024) |
| Amgen Inc. | $388.37 | 17 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $381.03 | 20 | $0 (2022) |
| GlaxoSmithKline, LLC. | $357.36 | 16 | $0 (2023) |
| Collegium Pharmaceutical, Inc. | $293.27 | 17 | $0 (2023) |
| Lilly USA, LLC | $278.29 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $645.03 | 23 | Mallinckrodt Hospital Products Inc. ($288.81) |
| 2023 | $715.65 | 32 | ABBVIE INC. ($300.88) |
| 2022 | $618.85 | 30 | ABBVIE INC. ($199.99) |
| 2021 | $302.00 | 15 | PFIZER INC. ($65.66) |
| 2020 | $245.00 | 10 | AbbVie Inc. ($96.70) |
| 2019 | $1,339 | 65 | BioDelivery Sciences International, Inc. ($176.99) |
| 2018 | $1,731 | 83 | BioDelivery Sciences International, Inc. ($356.92) |
| 2017 | $1,540 | 71 | Depomed, Inc. ($161.03) |
All Payment Transactions
329 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $30.38 | General |
| Category: IMMUNOLOGY | ||||||
| 11/01/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $31.02 | General |
| Category: IMMUNOLOGY | ||||||
| 10/18/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: IMMUNOLOGY | ||||||
| 09/24/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: IMMUNOLOGY | ||||||
| 08/19/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $30.21 | General |
| Category: Inflammation | ||||||
| 07/30/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: IMMUNOLOGY | ||||||
| 07/11/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $30.51 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 06/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $27.57 | General |
| Category: IMMUNOLOGY | ||||||
| 05/21/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: IMMUNOLOGY | ||||||
| 05/03/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $29.81 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 04/02/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $28.13 | General |
| Category: IMMUNOLOGY | ||||||
| 03/19/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $26.46 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 03/13/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $11.58 | General |
| Category: IMMUNOLOGY | ||||||
| 03/07/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $121.60 | General |
| Category: IMMUNOLOGY | ||||||
| 02/13/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: IMMUNOLOGY | ||||||
| 02/06/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: Immunology | ||||||
| 02/02/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $30.90 | General |
| Category: IMMUNOLOGY | ||||||
| 01/23/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: IMMUNOLOGY | ||||||
| 01/18/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: IMMUNOLOGY | ||||||
| 01/05/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $24.84 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/01/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $25.25 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $27.00 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 143 | 355 | $54,245 | $25,347 |
| 2022 | 8 | 239 | 918 | $113,665 | $49,421 |
| 2021 | 8 | 247 | 867 | $114,616 | $53,438 |
| 2020 | 7 | 246 | 789 | $96,862 | $45,262 |
Total Patients
875
Total Services
2,929
Medicare Billing
$173,468
Procedure Codes
29
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 24 | 103 | $12,875 | $6,751 | 52.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 17 | 102 | $15,300 | $6,164 | 40.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 43 | 46 | $9,200 | $4,493 | 48.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 23 | 55 | $8,050 | $2,879 | 35.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 21 | 21 | $3,640 | $2,757 | 75.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 15 | 28 | $5,180 | $2,304 | 44.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 38 | 295 | $44,250 | $15,853 | 35.8% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 18 | 291 | $17,460 | $8,663 | 49.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 68 | 79 | $15,800 | $8,025 | 50.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 35 | 120 | $15,025 | $7,819 | 52.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 24 | 70 | $9,900 | $2,901 | 29.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 19 | 23 | $4,255 | $2,152 | 50.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 16 | 16 | $2,775 | $2,150 | 77.5% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 21 | 24 | $4,200 | $1,858 | 44.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 39 | 400 | $53,745 | $22,200 | 41.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 38 | 153 | $19,125 | $10,395 | 54.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 68 | 73 | $14,600 | $7,749 | 53.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 35 | 73 | $9,825 | $3,358 | 34.2% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 15 | 105 | $6,181 | $3,144 | 50.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 15 | 22 | $4,050 | $2,355 | 58.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 17 | 17 | $2,890 | $2,345 | 81.1% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 20 | 24 | $4,200 | $1,893 | 45.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 53 | 254 | $26,670 | $13,990 | 52.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 85 | 102 | $20,400 | $10,998 | 53.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 44 | 207 | $31,050 | $10,311 | 33.2% |
About Dr. Jack Mourad, M.D
Dr. Jack Mourad, M.D is a Emergency Medicine healthcare provider based in Cranston, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1912972050.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jack Mourad, M.D has received a total of $7,137 in payments from pharmaceutical and medical device companies, with $645.03 received in 2024. These payments were reported across 329 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($7,074).
As a Medicare-enrolled provider, Mourad has provided services to 875 Medicare beneficiaries, totaling 2,929 services with total Medicare billing of $173,468. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Ad
Practice Information
- Specialty Emergency Medicine
- Other Specialties Rheumatology
- Location Cranston, RI
- Active Since 02/22/2006
- Last Updated 12/22/2008
- Taxonomy Code 207P00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1912972050
Products in Payments
- ACTHAR (Biological) $627.26
- Cimzia (Drug) $583.78
- RINVOQ (Biological) $568.24
- XELJANZ (Drug) $431.16
- BELBUCA (Drug) $402.23
- BENLYSTA (Biological) $324.26
- FARXIGA (Drug) $301.80
- Enbrel (Biological) $296.82
- BUNAVAIL 2.1 mg 30-count box (Drug) $215.41
- ORENCIA (Biological) $192.78
- TALTZ (Drug) $162.50
- Nucynta (Drug) $161.03
- Movantik (Drug) $148.98
- KRYSTEXXA (Drug) $148.83
- KEVZARA SARILUMAB INJECTION (Biological) $140.89
- Xtampza ER (Drug) $138.14
- KRYSTEXXA (Biological) $136.51
- XTAMPZA (Drug) $123.81
- SKYRIZI (Biological) $118.24
- Humira (Biological) $114.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.